Zymeworks - Stock Price History | ZYME

Historical daily share price chart and data for Zymeworks since 2021 adjusted for splits. The latest closing stock price for Zymeworks as of October 22, 2021 is 23.00.
  • The all-time high Zymeworks stock closing price was 56.81 on January 08, 2021.
  • The Zymeworks 52-week high stock price is 59.03, which is 156.7% above the current share price.
  • The Zymeworks 52-week low stock price is 22.42, which is 2.5% below the current share price.
  • The average Zymeworks stock price for the last 52 weeks is 36.78.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Zymeworks Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 39.6340 47.5900 54.9900 24.2800 47.2600 3.96%
2019 23.9340 14.6900 45.4600 14.0200 45.4600 209.67%
2018 13.4640 7.9332 21.8600 7.9332 14.6800 93.33%
2017 8.8343 13.0000 13.2800 6.4800 7.5931 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.088B $0.039B
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.460B 8.55
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.211B 20.68
Biohaven Pharmaceutical Holding (BHVN) United States $8.952B 0.00
Emergent Biosolutions (EBS) United States $2.717B 6.55
Arcus Biosciences (RCUS) United States $2.502B 0.00
Myovant Sciences (MYOV) United Kingdom $1.906B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.820B 0.00
Ambrx Biopharma (AMAM) United States $0.513B 0.00
SQZ Biotechnologies (SQZ) United States $0.343B 0.00
Enzo Biochem (ENZ) United States $0.159B 15.57